Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 106   

Articles published

NVS 88.44 +0.23 (0.26%)
price chart
Watch List - Incyte Corporation (INCY), Novartis AG (ADR) (NVS), ACADIA ...
Novartis AG (ADR) (NYSE:NVS) deals in patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical ...
Stocks Roundup - Novartis AG (ADR)(NYSE:NVS), MELA Sciences Inc ...
Las Vegas, NV - July 5, 2014 - (TechSonian) �Novartis AG (ADR)( NYSE:NVS) offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, ...
Notable Movers: Novartis AG (ADR) (NYSE:NVS), Pfizer Inc. (NYSE:PFE), Abbott ...
Novartis AG (NYSE:NVS) announced that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients ...
Notable Stocks: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA ...  Crazy Joys
Related articles »  
Trending Stocks: Novartis AG (ADR) (NYSE:NVS), Yum! Brands, Inc. (NYSE ...
Swiss pharmaceutical giant Novartis AG (NYSE:NVS) Thursday said its second-quarter profit improved slightly from the prior year, amid a small growth in sales.
Trending Stocks: Yahoo Inc. (NASDAQ:YHOO), eBay Inc (NASDAQ:EBAY ...  Markets Insider
Stock Alert: Nokia Corporation (ADR) (NYSE:NOK), Microsoft Corporation ...  Crazy Joys
Related articles »  
Two Cancer Stocks Take Shots On Goal [Exelixis, Inc., Medivation Inc, Ariad ...
EH: First of all, Iclusig is already approved, both in the U.S. and Europe, although for a much narrower indication. The drug seems to be very effective compared to standard-of-care treatment, which is Novartis AG's (NVS:NYSE) Gleevec (imatinib mesylate).
Novartis AG Given �Neutral� Rating at Zacks (NVS)
Novartis AG (ADR) logo Zacks restated their neutral rating on shares of Novartis AG (NYSE:NVS) in a report released on Friday.
Related articles »  
Notable Stocks: Merck (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Novartis ...
Novartis AG (ADR) (NYSE:NVS) announced that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2014-2015 season.
Related articles »  
Hot Movers: Red Hat Inc. (NYSE:RHT), Novartis (NYSE:NVS), Abbott ...
Tokyo prosecutors charged Novartis AG (ADR) (NYSE:NVS) Pharma K.K. and a former employee Tuesday with causing a medical research team to release data manipulated in favor of the firm's drug for treating high blood pressure in 2011.
Related articles »  
Zacks Reiterates "Neutral" Rating for Novartis AG (NVS)
Novartis AG (ADR) logo Novartis AG (NYSE:NVS)'s stock had its �neutral� rating reaffirmed by Zacks in a research note issued to investors on Friday.
Notable Movers: AstraZeneca plc (ADR) (NYSE:AZN), Intercept Pharmaceuticals ...
Novartis AG (ADR) (NYSE:NVS) net profit margin is 16.50% and weekly performance is -1.84%. On last trading day company shares ended up $89.81.